Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022
$AERI
$ANET
$AVB
$AVLR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Computer Communications Equipment
Telecommunications
Upgrades
- According to Citigroup, the prior rating for Cyxtera Technologies Inc (NASDAQ:CYXT) was changed from Neutral to Buy. The current stock performance of Cyxtera Technologies shows a 52-week-high of $15.42 and a 52-week-low of $7.09. Moreover, at the end of the last trading period, the closing price was at $7.55.
- For Centennial Resource Development Inc (NASDAQ:CDEV), Truist Securities upgraded the previous rating of Hold to Buy. For the second quarter, Centennial Resource Dev had an EPS of $0.60, compared to year-ago quarter EPS of $0.03. At the moment, the stock has a 52-week-high of $9.70 and a 52-week-low of $5.08. Centennial Resource Dev closed at $7.74 at the end of the last trading period.
- Wolfe Research upgraded the previous rating for Prologis Inc (NYSE:PLD) from Peer Perform to Outperform. In the second quarter, Prologis showed an EPS of $1.11, compared to $1.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $174.54 and a 52-week-low of $106.46. Prologis closed at $128.46 at the end of the last trading period.
- For AvalonBay Communities Inc (NYSE:AVB), Wolfe Research upgraded the previous rating of Peer Perform to Outperform. In the second quarter, AvalonBay Communities showed an EPS of $2.43, compared to $1.98 from the year-ago quarter. At the moment, the stock has a 52-week-high of $259.05 and a 52-week-low of $183.35. AvalonBay Communities closed at $206.67 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
- For Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), Roth Capital downgraded the previous rating of Buy to Neutral. For the second quarter, Catalyst Pharmaceuticals had an EPS of $0.28, compared to year-ago quarter EPS of $0.11. At the moment, the stock has a 52-week-high of $15.07 and a 52-week-low of $5.24. Catalyst Pharmaceuticals closed at $14.91 at the end of the last trading period.
- Truist Securities downgraded the previous rating for Aerie Pharmaceuticals Inc (NASDAQ:AERI) from Buy to Hold. For the second quarter, Aerie Pharmaceuticals had an EPS of $0.32, compared to year-ago quarter EPS of $0.84. The current stock performance of Aerie Pharmaceuticals shows a 52-week-high of $15.21 and a 52-week-low of $4.81. Moreover, at the end of the last trading period, the closing price was at $15.16.
- RBC Capital downgraded the previous rating for Bank of Nova Scotia (NYSE:BNS) from Outperform to Sector Perform. Bank of Nova Scotia earned $1.63 in the third quarter, compared to $1.64 in the year-ago quarter. The current stock performance of Bank of Nova Scotia shows a 52-week-high of $74.86 and a 52-week-low of $54.23. Moreover, at the end of the last trading period, the closing price was at $59.09.
- Rosenblatt downgraded the previous rating for Twitter Inc (NYSE:TWTR) from Buy to Neutral. Twitter earned $0.08 in the second quarter, compared to $0.20 in the year-ago quarter. The stock has a 52-week-high of $54.57 and a 52-week-low of $31.30. At the end of the last trading period, Twitter closed at $39.86.
- Morgan Stanley downgraded the previous rating for Foghorn Therapeutics Inc (NASDAQ:FHTX) from Overweight to Equal-Weight. In the second quarter, Foghorn Therapeutics showed an EPS of $0.66, compared to $0.63 from the year-ago quarter. The current stock performance of Foghorn Therapeutics shows a 52-week-high of $24.34 and a 52-week-low of $8.01. Moreover, at the end of the last trading period, the closing price was at $11.00.
- For Aerie Pharmaceuticals Inc (NASDAQ:AERI), HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. In the second quarter, Aerie Pharmaceuticals showed an EPS of $0.32, compared to $0.84 from the year-ago quarter. The current stock performance of Aerie Pharmaceuticals shows a 52-week-high of $15.21 and a 52-week-low of $4.81. Moreover, at the end of the last trading period, the closing price was at $15.16.
- Barclays downgraded the previous rating for XPeng Inc (NYSE:XPEV) from Overweight to Equal-Weight. XPeng earned $0.43 in the second quarter, compared to $0.21 in the year-ago quarter. The current stock performance of XPeng shows a 52-week-high of $51.50 and a 52-week-low of $18.01. Moreover, at the end of the last trading period, the closing price was at $18.73.
- According to Raymond James, the prior rating for Medtronic PLC (NYSE:MDT) was changed from Outperform to Market Perform. For the first quarter, Medtronic had an EPS of $1.13, compared to year-ago quarter EPS of $1.41. The current stock performance of Medtronic shows a 52-week-high of $114.31 and a 52-week-low of $86.70. Moreover, at the end of the last trading period, the closing price was at $90.22.
- For Avalara Inc (NYSE:AVLR), William Blair downgraded the previous rating of Outperform to Market Perform. For the second quarter, Avalara had an EPS of $0.02, compared to year-ago quarter EPS of $0.02. At the moment, the stock has a 52-week-high of $129.34 and a 52-week-low of $66.39. Avalara closed at $91.90 at the end of the last trading period.
- According to BMO Capital, the prior rating for Bank of Nova Scotia (NYSE:BNS) was changed from Outperform to Market Perform. In the third quarter, Bank of Nova Scotia showed an EPS of $1.63, compared to $1.64 from the year-ago quarter. The stock has a 52-week-high of $74.86 and a 52-week-low of $54.23. At the end of the last trading period, Bank of Nova Scotia closed at $59.09.
See all analyst ratings downgrades.
Initiations
- Fox Advisors initiated coverage on Benchmark Electronics Inc (NYSE:BHE) with an Overweight rating. The price target for Benchmark Electronics is set to $35.00. Benchmark Electronics earned $0.50 in the second quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $28.87 and a 52-week-low of $21.11. Benchmark Electronics closed at $27.66 at the end of the last trading period.
- B. Riley Securities initiated coverage on Establishment Labs Holdings Inc (NASDAQ:ESTA) with a Buy rating. The price target for Establishment Labs Hldgs is set to $107.00. Establishment Labs Hldgs earned $1.52 in the second quarter, compared to $0.22 in the year-ago quarter. At the moment, the stock has a 52-week-high of $93.80 and a 52-week-low of $46.93. Establishment Labs Hldgs closed at $62.52 at the end of the last trading period.
- With a Buy rating, EF Hutton initiated coverage on FiscalNote Holdings Inc (NYSE:NOTE). The price target seems to have been set at $12.00 for FiscalNote Holdings. At the moment, the stock has a 52-week-high of $12.30 and a 52-week-low of $5.55. FiscalNote Holdings closed at $10.32 at the end of the last trading period.
- JMP Securities initiated coverage on VICI Properties Inc (NYSE:VICI) with a Market Outperform rating. The price target for VICI Properties is set to $38.00. For the second quarter, VICI Properties had an EPS of $0.48, compared to year-ago quarter EPS of $0.46. The stock has a 52-week-high of $35.69 and a 52-week-low of $26.23. At the end of the last trading period, VICI Properties closed at $33.69.
- Deutsche Bank initiated coverage on Arista Networks Inc (NYSE:ANET) with a Hold rating. The price target for Arista Networks is set to $135.00. For the second quarter, Arista Networks had an EPS of $1.08, compared to year-ago quarter EPS of $0.68. The current stock performance of Arista Networks shows a 52-week-high of $144.50 and a 52-week-low of $89.11. Moreover, at the end of the last trading period, the closing price was at $126.96.